Comparative Study
Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366
- PMID: 4398186
Item in Clipboard
Comparative Study
Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366
J Pharmacol Exp Ther.
1971 Feb.
No abstract available
Similar articles
-
Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.J Clin Pharmacol New Drugs. 1971 Jul-Aug;11(4):249-60. J Clin Pharmacol New Drugs. 1971. PMID: 4397374 No abstract available.
-
Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197).J Pharmacol Exp Ther. 1971 Mar;176(3):655-61. J Pharmacol Exp Ther. 1971. PMID: 4398744 No abstract available.
-
Pulmonary vascular and cardiac effects of glucagon before and after adrenergic beta-receptor blockade.Indian J Physiol Pharmacol. 1971 Oct;15(4):173-7. Indian J Physiol Pharmacol. 1971. PMID: 4401547 No abstract available.
-
[Role of the adrenergic mechanisms in the action of drugs on the cardiovascular system].Kardiol Pol. 1974;17(6):525-38. Kardiol Pol. 1974. PMID: 4155456 Review. Polish. No abstract available.
-
[Differentiation of adrenergic receptors and their variable importance in drug therapy].Dtsch Tierarztl Wochenschr (1946). 1969 Nov 15;76(22):617-21. Dtsch Tierarztl Wochenschr (1946). 1969. PMID: 4922890 Review. German. No abstract available.
Cited by
-
Some effects of Kö 1313 in animals and man.Br J Clin Pharmacol. 1974 Feb;1(1):27-35. doi: 10.1111/j.1365-2125.1974.tb00202.x. Br J Clin Pharmacol. 1974. PMID: 22454865 Free PMC article.
-
Haemodynamic response to graded exercise during chronic beta-adrenergic blockade with bunitrolol, an agent with intrinsic sympathomimetic activity.Eur J Clin Pharmacol. 1977 Dec 16;12(5):333-9. doi: 10.1007/BF00562447. Eur J Clin Pharmacol. 1977. PMID: 23295
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials